NCT07085728 2025-08-22Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney FailureEastern Cooperative Oncology GroupPhase 2 Not yet recruiting74 enrolled